The previous page is sending you to https://www.businesswire.com/news/home/20131219005548/en/APR-Applied-Pharma-Research-APR-and-Angelini-Enter-into-an-Exclusive-Licensing-Agreement-for-APR%E2%80%99s-Innovative-Product-in-Acute-and-Chronic-Wound-Management.

 If you do not want to visit that page, you can return to the previous page.